A government-appointed panel has agreed to review and potentially create rules responding to concerns about attorneys cherrypicking courts that they believe will be more sympathetic to their cases.
The practice, known as “judge shopping,” received significant attention after Texas Judge Matthew Kacsmaryk’s decision suspending the Food and Drug Administration’s approval of the abortion medication mifepristone in April. Senate Democrats cited that decision and other cases in Texas with a July letter asking the U.S. Judicial Conference’s Advisory Committee on Civil Rules to issue recommendations for reform.
